|
|
Volumn 15, Issue 5, 2010, Pages 512-514
|
|
Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: A case study
|
|
Author keywords
Hemodialysis; M 2; Renal cell carcinoma; Sorafenib
|
|
Indexed keywords
DRUG METABOLITE;
GAMMA INTERFERON;
SORAFENIB;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
BONE METASTASIS;
CANCER RADIOTHERAPY;
CASE REPORT;
CASE STUDY;
CHRONIC GLOMERULONEPHRITIS;
DIARRHEA;
DRUG BLOOD LEVEL;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
HEMODIALYSIS;
HUMAN;
HYPERAMYLASEMIA;
HYPERTENSION;
INTERSTITIAL PNEUMONIA;
KIDNEY CARCINOMA;
LYMPH NODE METASTASIS;
MALE;
MAXIMUM PLASMA CONCENTRATION;
NEPHRECTOMY;
PRIORITY JOURNAL;
SKIN MANIFESTATION;
TREATMENT DURATION;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
BIOTRANSFORMATION;
CARCINOMA, RENAL CELL;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
PROTEIN KINASE INHIBITORS;
PYRIDINES;
RENAL DIALYSIS;
TREATMENT OUTCOME;
|
|
EID: 78149359699
PISSN: 13419625
EISSN: None
Source Type: Journal
DOI: 10.1007/s10147-010-0070-9 Document Type: Article |
|
Times cited : (23)
|
|
References (6)
|
